These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23418321)

  • 1. CD44-positive cancer stem cells expressing cellular prion protein contribute to metastatic capacity in colorectal cancer.
    Du L; Rao G; Wang H; Li B; Tian W; Cui J; He L; Laffin B; Tian X; Hao C; Liu H; Sun X; Zhu Y; Tang DG; Mehrpour M; Lu Y; Chen Q
    Cancer Res; 2013 Apr; 73(8):2682-94. PubMed ID: 23418321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular prion protein accelerates colorectal cancer metastasis via the Fyn-SP1-SATB1 axis.
    Wang Q; Qian J; Wang F; Ma Z
    Oncol Rep; 2012 Dec; 28(6):2029-34. PubMed ID: 22972305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44/cellular prion protein interact in multidrug resistant breast cancer cells and correlate with responses to neoadjuvant chemotherapy in breast cancer patients.
    Cheng Y; Tao L; Xu J; Li Q; Yu J; Jin Y; Chen Q; Xu Z; Zou Q; Liu X
    Mol Carcinog; 2014 Sep; 53(9):686-97. PubMed ID: 23681900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer.
    Leng Z; Xia Q; Chen J; Li Y; Xu J; Zhao E; Zheng H; Ai W; Dong J
    Cell Physiol Biochem; 2018; 46(2):860-872. PubMed ID: 29627827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enrichment of colorectal cancer stem cells through epithelial-mesenchymal transition via CDH1 knockdown.
    Ye J; Wu D; Shen J; Wu P; Ni C; Chen J; Zhao J; Zhang T; Wang X; Huang J
    Mol Med Rep; 2012 Sep; 6(3):507-12. PubMed ID: 22684815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
    Wang D; Fu L; Sun H; Guo L; DuBois RN
    Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.
    Reeder JA; Gotley DC; Walsh MD; Fawcett J; Antalis TM
    Cancer Res; 1998 Aug; 58(16):3719-26. PubMed ID: 9721884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metastasis suppressor, NDRG1, inhibits "stemness" of colorectal cancer via down-regulation of nuclear β-catenin and CD44.
    Wangpu X; Yang X; Zhao J; Lu J; Guan S; Lu J; Kovacevic Z; Liu W; Mi L; Jin R; Sun J; Yue F; Ma J; Lu A; Richardson DR; Wang L; Zheng M
    Oncotarget; 2015 Oct; 6(32):33893-911. PubMed ID: 26418878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An hTERT/ZEB1 complex directly regulates E-cadherin to promote epithelial-to-mesenchymal transition (EMT) in colorectal cancer.
    Qin Y; Tang B; Hu CJ; Xiao YF; Xie R; Yong X; Wu YY; Dong H; Yang SM
    Oncotarget; 2016 Jan; 7(1):351-61. PubMed ID: 26540342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer stem-like cell marker CD44 promotes bone metastases by enhancing tumorigenicity, cell motility, and hyaluronan production.
    Hiraga T; Ito S; Nakamura H
    Cancer Res; 2013 Jul; 73(13):4112-22. PubMed ID: 23633482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance of the stemness in CD44(+) HCT-15 and HCT-116 human colon cancer cells requires miR-203 suppression.
    Ju SY; Chiou SH; Su Y
    Stem Cell Res; 2014 Jan; 12(1):86-100. PubMed ID: 24145190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular prion protein promotes glucose uptake through the Fyn-HIF-2α-Glut1 pathway to support colorectal cancer cell survival.
    Li QQ; Sun YP; Ruan CP; Xu XY; Ge JH; He J; Xu ZD; Wang Q; Gao WC
    Cancer Sci; 2011 Feb; 102(2):400-6. PubMed ID: 21265952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of the putative CD44+CD24- breast cancer stem cell population by targeting the polyamine metabolic pathway with PG11047.
    Cirenajwis H; Smiljanic S; Honeth G; Hegardt C; Marton LJ; Oredsson SM
    Anticancer Drugs; 2010 Nov; 21(10):897-906. PubMed ID: 20838207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LGR4 cooperates with PrPc to endow the stemness of colorectal cancer stem cells contributing to tumorigenesis and liver metastasis.
    Cheng Q; Zheng H; Li M; Wang H; Guo X; Zheng Z; Chen C; Liu J; Zhan T; Li Z; Wu H; Han J; Liu L; Tang T; Chen Q; Du L
    Cancer Lett; 2022 Aug; 540():215725. PubMed ID: 35561877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases.
    Jing F; Kim HJ; Kim CH; Kim YJ; Lee JH; Kim HR
    Int J Oncol; 2015 Apr; 46(4):1582-8. PubMed ID: 25625240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L1-mediated colon cancer cell metastasis does not require changes in EMT and cancer stem cell markers.
    Gavert N; Vivanti A; Hazin J; Brabletz T; Ben-Ze'ev A
    Mol Cancer Res; 2011 Jan; 9(1):14-24. PubMed ID: 21123622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRACHYURY confers cancer stem cell characteristics on colorectal cancer cells.
    Sarkar D; Shields B; Davies ML; Müller J; Wakeman JA
    Int J Cancer; 2012 Jan; 130(2):328-37. PubMed ID: 21365650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial to mesenchymal transition might be induced via CD44 isoform switching in colorectal cancer.
    Mashita N; Yamada S; Nakayama G; Tanaka C; Iwata N; Kanda M; Kobayashi D; Fujii T; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Kodera Y
    J Surg Oncol; 2014 Nov; 110(6):745-51. PubMed ID: 24975268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of DAB2IP promotes cancer stem cell like signatures and indicates poor survival outcome in colorectal cancer.
    Min J; Liu L; Li X; Jiang J; Wang J; Zhang B; Cao D; Yu D; Tao D; Hu J; Gong J; Xie D
    Sci Rep; 2015 Nov; 5():16578. PubMed ID: 26564738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CEA-/lo colorectal cancer cell population harbors cancer stem cells and metastatic cells.
    Yan C; Hu Y; Zhang B; Mu L; Huang K; Zhao H; Ma C; Li X; Tao D; Gong J; Qin J
    Oncotarget; 2016 Dec; 7(49):80700-80715. PubMed ID: 27813496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.